JP2010526076A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010526076A5 JP2010526076A5 JP2010506507A JP2010506507A JP2010526076A5 JP 2010526076 A5 JP2010526076 A5 JP 2010526076A5 JP 2010506507 A JP2010506507 A JP 2010506507A JP 2010506507 A JP2010506507 A JP 2010506507A JP 2010526076 A5 JP2010526076 A5 JP 2010526076A5
- Authority
- JP
- Japan
- Prior art keywords
- crig
- antibody
- composition
- fragment
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101000743488 Homo sapiens V-set and immunoglobulin domain-containing protein 4 Proteins 0.000 claims description 54
- 102100038296 V-set and immunoglobulin domain-containing protein 4 Human genes 0.000 claims description 54
- 239000005557 antagonist Substances 0.000 claims description 48
- 239000012634 fragment Substances 0.000 claims description 22
- 244000052769 pathogen Species 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 17
- 230000001717 pathogenic effect Effects 0.000 claims description 13
- 241000124008 Mammalia Species 0.000 claims description 10
- 230000003834 intracellular effect Effects 0.000 claims description 10
- 241000700605 Viruses Species 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 4
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 4
- 241000701022 Cytomegalovirus Species 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 4
- 241000701044 Human gammaherpesvirus 4 Species 0.000 claims description 4
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 4
- 241000701806 Human papillomavirus Species 0.000 claims description 4
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 4
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 4
- 102000029797 Prion Human genes 0.000 claims description 4
- 108091000054 Prion Proteins 0.000 claims description 4
- 241000700584 Simplexvirus Species 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 4
- 230000001419 dependent effect Effects 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 230000001404 mediated effect Effects 0.000 claims description 4
- 244000045947 parasite Species 0.000 claims description 4
- 230000017531 blood circulation Effects 0.000 claims description 3
- 208000035473 Communicable disease Diseases 0.000 claims description 2
- 108010078015 Complement C3b Proteins 0.000 claims description 2
- 208000006454 hepatitis Diseases 0.000 claims description 2
- 231100000283 hepatitis Toxicity 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 230000001413 cellular effect Effects 0.000 claims 1
- 230000004087 circulation Effects 0.000 claims 1
- 238000000034 method Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91534007P | 2007-05-01 | 2007-05-01 | |
| PCT/US2008/061513 WO2008137338A1 (en) | 2007-05-01 | 2008-04-25 | CRIg ANTAGONISTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010526076A JP2010526076A (ja) | 2010-07-29 |
| JP2010526076A5 true JP2010526076A5 (OSRAM) | 2012-05-31 |
Family
ID=39645433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010506507A Pending JP2010526076A (ja) | 2007-05-01 | 2008-04-25 | ＣＲＩｇアンタゴニスト |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20090162356A1 (OSRAM) |
| EP (1) | EP2152749A1 (OSRAM) |
| JP (1) | JP2010526076A (OSRAM) |
| KR (1) | KR20100018523A (OSRAM) |
| CN (1) | CN101675078A (OSRAM) |
| AR (1) | AR066375A1 (OSRAM) |
| AU (1) | AU2008247958A1 (OSRAM) |
| BR (1) | BRPI0810926A2 (OSRAM) |
| CA (1) | CA2682835A1 (OSRAM) |
| CL (1) | CL2008001238A1 (OSRAM) |
| IL (1) | IL201165A0 (OSRAM) |
| MX (1) | MX2009011407A (OSRAM) |
| PE (1) | PE20090239A1 (OSRAM) |
| RU (1) | RU2009144280A (OSRAM) |
| WO (1) | WO2008137338A1 (OSRAM) |
| ZA (1) | ZA200906812B (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
| PE20141549A1 (es) | 2008-05-06 | 2014-10-25 | Genentech Inc | VARIANTES DE CRIg MADURAS POR AFINIDAD |
| US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
| US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
| US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
| US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
| US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
| CN104231085B (zh) * | 2013-09-05 | 2017-03-15 | 复旦大学附属肿瘤医院 | 靶向特异性补体系统抑制剂、其制备方法及应用 |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| CN105924515B (zh) * | 2016-04-25 | 2019-06-14 | 中国人民解放军第三军医大学 | 免疫共刺激分子vsig4激活性表位肽、单克隆抗体及其制备方法和应用 |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| WO2019005817A2 (en) | 2017-06-26 | 2019-01-03 | Bio-Techne Corporation | HYBRIDOMIC CLONES, MONOCLONAL ANTIBODIES DIRECTED AGAINST VSIG-4, AND METHODS OF MAKING AND USING SAME |
| KR102857892B1 (ko) * | 2018-09-28 | 2025-09-10 | 주식회사 유틸렉스 | 항-인간 vsig4 항체 및 이의 용도 |
| US20220233756A1 (en) * | 2019-05-17 | 2022-07-28 | George A. Herzlinger | Methods and systems for treating microbial disease |
| EP4025606A1 (en) * | 2019-09-04 | 2022-07-13 | Y-Biologics Inc. | Anti-vsig4 antibody or antigen binding fragment and uses thereof |
| US20240158503A1 (en) | 2021-03-03 | 2024-05-16 | Pierre Fabre Medicament | Anti-vsig4 antibody or antigen binding fragment and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8088386B2 (en) * | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
-
2008
- 2008-04-25 JP JP2010506507A patent/JP2010526076A/ja active Pending
- 2008-04-25 WO PCT/US2008/061513 patent/WO2008137338A1/en not_active Ceased
- 2008-04-25 CA CA002682835A patent/CA2682835A1/en not_active Abandoned
- 2008-04-25 AU AU2008247958A patent/AU2008247958A1/en not_active Abandoned
- 2008-04-25 EP EP08769166A patent/EP2152749A1/en not_active Withdrawn
- 2008-04-25 MX MX2009011407A patent/MX2009011407A/es active IP Right Grant
- 2008-04-25 US US12/150,220 patent/US20090162356A1/en not_active Abandoned
- 2008-04-25 CN CN200880014866A patent/CN101675078A/zh active Pending
- 2008-04-25 BR BRPI0810926-5A2A patent/BRPI0810926A2/pt not_active IP Right Cessation
- 2008-04-25 KR KR1020097024920A patent/KR20100018523A/ko not_active Withdrawn
- 2008-04-25 RU RU2009144280/10A patent/RU2009144280A/ru not_active Application Discontinuation
- 2008-04-30 AR ARP080101847A patent/AR066375A1/es not_active Application Discontinuation
- 2008-04-30 PE PE2008000774A patent/PE20090239A1/es not_active Application Discontinuation
- 2008-04-30 CL CL2008001238A patent/CL2008001238A1/es unknown
-
2009
- 2009-09-24 IL IL201165A patent/IL201165A0/en unknown
- 2009-09-30 ZA ZA2009/06812A patent/ZA200906812B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010526076A5 (OSRAM) | ||
| RU2009144280A (ru) | АНТАГОНИСТЫ CRIg | |
| JP2011505867A5 (OSRAM) | ||
| JP2018506966A5 (OSRAM) | ||
| JP2018035138A5 (OSRAM) | ||
| JP2018535650A5 (OSRAM) | ||
| JP2018500014A5 (OSRAM) | ||
| JP2018521638A5 (OSRAM) | ||
| RU2012153968A (ru) | Композиции и способы лечения инфекций и опухолей | |
| JP2017536341A5 (OSRAM) | ||
| RU2019111722A (ru) | Антитела против siglec-15 и способы их применения | |
| JP2011527902A5 (OSRAM) | ||
| AR109882A1 (es) | Anticuerpos monoclonales neutralizantes anti-tl1a | |
| JP2012254092A5 (OSRAM) | ||
| CA2952055A1 (en) | Monoclonal antibodies for ebola and marburg viruses | |
| JP2011527899A5 (OSRAM) | ||
| FI2897981T3 (fi) | Anti-CD3-vasta-aineita, bispesifisiä antigeeniä sitovia molekyylejä, jotka sitovat CD3:a ja CD20:ta, ja niiden käyttöjä | |
| JP2017534577A5 (OSRAM) | ||
| JP2018520334A5 (OSRAM) | ||
| JP2006020633A (ja) | 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法 | |
| JP2015503909A5 (OSRAM) | ||
| JPWO2019246514A5 (OSRAM) | ||
| RU2014143785A (ru) | Фармацевтическая композиция для лечения и/или предотвращения рака печени | |
| RU2016100892A (ru) | Антитела против tweakr и их применение | |
| JP2017507657A5 (OSRAM) |